Health
Insulin Shortage Affects Patients
A shortage of the Lantus Solostar insulin pen is affecting patients, despite it not being officially listed as a FDA shortage. This issue highlights ongoing challenges in pharmaceutical supply chains.
Coverage timeline — 1 article
STAT News
The Lantus Solostar insulin pen isn't in official FDA shortage, but patients are having a tough time finding it.
2026-07-23 16:23 UTC